148 related articles for article (PubMed ID: 37865305)
1. CD95 (Fas) and CD95L (FasL)-mediated non-canonical signaling pathways.
Haymour L; Jean M; Smulski C; Legembre P
Biochim Biophys Acta Rev Cancer; 2023 Nov; 1878(6):189004. PubMed ID: 37865305
[TBL] [Abstract][Full Text] [Related]
2. Role of metalloproteases in the CD95 signaling pathways.
Devel L; Guedeney N; Bregant S; Chowdhury A; Jean M; Legembre P
Front Immunol; 2022; 13():1074099. PubMed ID: 36544756
[TBL] [Abstract][Full Text] [Related]
3. Non-apoptotic Fas signaling.
Wajant H; Pfizenmaier K; Scheurich P
Cytokine Growth Factor Rev; 2003 Feb; 14(1):53-66. PubMed ID: 12485619
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic approaches targeting CD95L/CD95 signaling in cancer and autoimmune diseases.
Risso V; Lafont E; Le Gallo M
Cell Death Dis; 2022 Mar; 13(3):248. PubMed ID: 35301281
[TBL] [Abstract][Full Text] [Related]
5. CD95/Fas, Non-Apoptotic Signaling Pathways, and Kinases.
Le Gallo M; Poissonnier A; Blanco P; Legembre P
Front Immunol; 2017; 8():1216. PubMed ID: 29021794
[TBL] [Abstract][Full Text] [Related]
6. CD95 Stimulation with CD95L and DISC Analysis.
Le Gallo M; Legembre P
Methods Mol Biol; 2017; 1557():11-18. PubMed ID: 28078578
[TBL] [Abstract][Full Text] [Related]
7. Cytoplasmic overexpression of CD95L in esophageal adenocarcinoma cells overcomes resistance to CD95-mediated apoptosis.
Watson GA; Naran S; Zhang X; Stang MT; Queiroz de Oliveira PE; Hughes SJ
Neoplasia; 2011 Mar; 13(3):198-205. PubMed ID: 21390183
[TBL] [Abstract][Full Text] [Related]
8. CRISPR/Cas9-mediated abrogation of CD95L/CD95 signaling-induced glioma cell growth and immunosuppression increases survival in murine glioma models.
Quijano-Rubio C; Silginer M; Weller M
J Neurooncol; 2022 Nov; 160(2):299-310. PubMed ID: 36355258
[TBL] [Abstract][Full Text] [Related]
9. Function and regulation of the CD95 (APO-1/Fas) ligand in the immune system.
Li-Weber M; Krammer PH
Semin Immunol; 2003 Jun; 15(3):145-57. PubMed ID: 14563113
[TBL] [Abstract][Full Text] [Related]
10. Functional CD95 ligand and CD95 death-inducing signaling complex in activation-induced cell death and doxorubicin-induced apoptosis in leukemic T cells.
Fulda S; Strauss G; Meyer E; Debatin KM
Blood; 2000 Jan; 95(1):301-8. PubMed ID: 10607716
[TBL] [Abstract][Full Text] [Related]
11. Signaling active CD95 receptor molecules trigger co-translocation of inactive CD95 molecules into lipid rafts.
Lang I; Fick A; Schäfer V; Giner T; Siegmund D; Wajant H
J Biol Chem; 2012 Jul; 287(28):24026-42. PubMed ID: 22645131
[TBL] [Abstract][Full Text] [Related]
12. Nonapoptotic functions of Fas/CD95 in the immune response.
Guégan JP; Legembre P
FEBS J; 2018 Mar; 285(5):809-827. PubMed ID: 29032605
[TBL] [Abstract][Full Text] [Related]
13. The CD95/CD95L signaling pathway: a role in carcinogenesis.
Fouqué A; Debure L; Legembre P
Biochim Biophys Acta; 2014 Aug; 1846(1):130-41. PubMed ID: 24780723
[TBL] [Abstract][Full Text] [Related]
14. Hyperosmolarity triggers CD95 membrane trafficking and sensitizes rat hepatocytes toward CD95L-induced apoptosis.
Reinehr R; Graf D; Fischer R; Schliess F; Häussinger D
Hepatology; 2002 Sep; 36(3):602-14. PubMed ID: 12198652
[TBL] [Abstract][Full Text] [Related]
15. DICE: A novel tumor surveillance mechanism-a new therapy for cancer?
Peter ME
Cell Cycle; 2014; 13(9):1373-8. PubMed ID: 24690893
[TBL] [Abstract][Full Text] [Related]
16. Regulation of Fas (CD95)-induced apoptosis by nuclear factor-kappaB and tumor necrosis factor-alpha in macrophages.
Lu B; Wang L; Medan D; Toledo D; Huang C; Chen F; Shi X; Rojanasakul Y
Am J Physiol Cell Physiol; 2002 Sep; 283(3):C831-8. PubMed ID: 12176740
[TBL] [Abstract][Full Text] [Related]
17. CD95 signaling in cancer treatment.
De la Rosa AJ; Gomez MA; Morales S; Padillo FJ; Muntane J
Curr Pharm Des; 2014; 20(17):2809-18. PubMed ID: 23944368
[TBL] [Abstract][Full Text] [Related]
18. CD95/Fas ligand induced toxicity.
Haluck-Kangas A; Peter ME
Biochem Soc Trans; 2023 Feb; 51(1):21-29. PubMed ID: 36629505
[TBL] [Abstract][Full Text] [Related]
19. The naturally processed CD95L elicits a c-yes/calcium/PI3K-driven cell migration pathway.
Tauzin S; Chaigne-Delalande B; Selva E; Khadra N; Daburon S; Contin-Bordes C; Blanco P; Le Seyec J; Ducret T; Counillon L; Moreau JF; Hofman P; Vacher P; Legembre P
PLoS Biol; 2011 Jun; 9(6):e1001090. PubMed ID: 21713032
[TBL] [Abstract][Full Text] [Related]
20. Peripheral T and putative natural killer cell lymphomas commonly coexpress CD95 and CD95 ligand.
Ng CS; Lo ST; Chan JK
Hum Pathol; 1999 Jan; 30(1):48-53. PubMed ID: 9923926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
